Trial
NCT02470065
Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
—
Condition
Non Small Cell Lung Cancer
Intervention
Afatinib
Why stopped
Study never started
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-22